. These immune responses have been shown to develop both systemically and within the local oral environment, for example gingival crevicular fluid and saliva (Ebersole, 2003; Salminen et al., 2014) . Epidemiological studies and clinical observations have reported that the prevalence and severity of periodontitis increase with age (Baelum & Lopez, 2013; Eke, Dye, Wei, Thornton-Evans, & Genco, 2012; Eke et al., 2015) . However, we have a rather limited understanding of (i) how ageing affects the adaptive immune system responses to the bacteria that chronically colonize the oral cavity prior to disease and (ii) how the magnitude and specificity of the response interface with pathogens that emerge within the bacterial ecology during exacerbations of disease.
Age-related decreases in the innate and adaptive immune systems are defined as immunosenescence (O'Connor et al., 2014) . Increases in the incidence of inflammation, autoimmunity, cancer and susceptibility to infections coincide with this decline in host immunity and the efficacy of vaccinations in ageing individuals (Mabbott et al., 2015; Taverna et al., 2014) . Thus, a large body of work suggests that immune capabilities are dysregulated in ageing, including T cells, PMNs and B cells (Castelo-Branco & Soveral, 2014; Fulop, Witkowski, Pawelec, Alan, & Larbi, 2014; Muller & Pawelec, 2015; Sato, Kiyono, & Fujihashi, 2015; Shaw, Goldstein, & Montgomery, 2013) . The adaptive immune system with its broad range of antigen receptors creating specificity for these immune responses requires highly regulated cellular interactions among cells carrying specific antigenic receptors, cellular activation and molecular effector functions. Thus, ageing appears to functionally impair dendritic cell uptake of antigens, phagocytosis of apoptotic cells and migration and priming of both CD4 + and CD8 + T cells (Gupta, 2014) . To avoid adverse responses such as autoimmunity and immunopathology, checkpoints are built into the system for controlling both the responses and the production of effector molecules and appear to be compromised with ageing, resulting in inadequate immune control and unwanted responses. Deterioration of the immune system (i.e. immunosenescence) in humans has generally been documented at the population level, although a clear increase in variation of response profiles is noted with ageing. As such, reports use group averages of immune phenotypes, while this variation in immune system capacity and functions needs to be more clearly delineated at the individual level to discover critical regulators of altered immune states that reflect biologic and chronologic age (Shen-Orr & Furman, 2013) .
This study examined specific antibody responses in serum of a population of patients defined as periodontally healthy or expressing gingivitis or periodontitis at various levels. Including subjects from 21
to 74 with health and disease, we hypothesized that these systemic responses to chronic oral colonization/infection across the lifespan would be impacted by the ageing process, independent of disease.
| MATERIAL S AND ME THODS

| Patients and clinical measures
The demographics of the 447 patient population is depicted in Table 1 . Clinical measures included sites bleeding on probing (BOP), mean probing pocket depth (PPD), frequency of sites with PPD ≥ 4 mm and ≥5 mm, mean clinical attachment loss (CAL) and frequency of sites with CAL > 2 mm Preshaw et al., 2008) . Healthy subjects were defined by <10% of sites with BOP ≥ 1, <5% sites with PPD ≥ 4 mm and no sites with PPD ≥ 5 mm. Gingivitis was defined by >10% sites with BOP ≥ 1, <10% sites with PPD ≥ 4 mm and no sites with PPD ≥ 5 mm.
Periodontitis was defined by >10% BOP ≥1, ≥10% of sites with PPD ≥4 mm and ≥3% sites with CAL > 2 mm. Periodontitis was categorized into mild (mean PPD < 3 mm), moderate (mean PPD 3-4 mm) and severe (mean PPD > 4 mm).
| Samples
Specimens collected from the patients included subgingival plaque samples derived from a periodontally diseased site and a healthy site (Kirakodu, Govindaswami, Novak, Ebersole, & Novak, 2008; in each of 132 subjects. These were collected, DNA prepared and qPCR conducted for Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia, as we have described previously, and total bacteria in the samples were determined using a universal prokaryotic primer set .
Venipuncture blood was collected (10 ml) and serum prepared, aliquoted and stored frozen at −80°C.
Clinical Relevance
Scientific rationale for the study: The effect of ageing on humoral immune responses and their role in susceptibility or resistance to periodontitis is unclear. The general paradigm is that ageing disrupts normal innate and adaptive immune response processes. However, previous reports have identified elevations in antibody to periodontal pathogens in older populations, but did not discriminate the effects of ageing from the effects of the expression of periodontitis.
Principal findings:
The data demonstrated that ageing did not appear to impact the levels of antibody to a range of oral bacteria considered to be pathogens and commensals, independent of the substantial effects of periodontitis.
However, the characteristics of the antibody related to the bacterial burden and the clinical measures were significantly affected with ageing and disease severity.
Practical implications:
As the field attempts to better delineate the biologic underpinnings of the variation age of onset, extent and severity of disease, and rapidity and continuity of disease exacerbation, understanding the parameters of humoral immunity to the established oral microbiome should contribute in modelling precision periodontal medicine in the future.
| Bacterial antigens and serum antibody measures
Whole formalin-fixed bacteria were used as antigens to detect serum IgG antibody levels (Ebersole et al., 1987) . The antigens included P. gingivalis (ATCC33277), Aggregatibacter actinomycetem-
Actinomyces naeslundii (ATCC39340), Capnocytophaga ochracea (ATCC33596), Prevotella loescheii (ATCC15930), Streptococcus sanguinis (ATCC10556) and Veillonella parvula (ATCC10790) cultured as we have described previously (Hayman et al., 2011) . The quantification of the antibody was based upon parallel standard IgG curves incorporated into each plate of the experimental samples (Ebersole et al., 2009 ).
| Statistical analysis
Analyses of any differences among inflammatory mediators and IgG antibody levels were conducted via a Kruskal-Wallis ANOVA with post hoc testing of paired groups using a Dunn's method (SigmaStat, Systat Software, Inc., Richmond, CA, USA). Evaluation of the significance of correlation data was performed using the Spearman Correlation test. Results with an alpha of <.05 (after being adjusted for the multiple comparisons) were accepted as statistically significant.
| RE SULTS
While existing epidemiological data demonstrate clear increases in the prevalence of periodontitis with ageing (Eke et al., 2012 (Eke et al., , 2015 Eke et al., 2016a) , generally, this is reflected by increases in the proportion of moderate periodontitis, with only slight changes in mild and severe periodontitis over the 30 to 80-year age range.
However, we wanted to more clearly define the characteristics of clinical periodontal parameters in our cohort of healthy, gingivitis and periodontitis over the five-decade age range. Figure 1a -d provides a summary of these findings and demonstrate no significant difference in % BOP, mean probing pocket depth or frequency of pockets with >4 mm or >5 mm pockets related to age stratification of the patients in each clinical category. As would be expected, the periodontitis group exhibited higher levels of these parameters versus the healthy and gingivitis subjects.
Serum antibody levels were evaluated related to the age of the patient. As shown in Figure 2a -c, no differences were noted in antibody to P. gingivalis, T. denticola or T. forsythia related to age categories, or antibody to a group of pathogens or commensal bacteria within the periodontitis group. As would be expected from the literature, serum antibody to individual bacteria, particularly, the pathogens, was significantly different in periodontitis patients compared to age-matched subsets with gingivitis or a healthy periodontium. Interestingly, the youngest group of gingivitis patients showed significantly elevated antibody to P. gingvalis, T. denticola TA B L E 1 Demographics of the population and A. actinomycetemcomitans and the sum of antibody to the pathogens compared to healthy individuals, which was not observed in the older gingivitis groups. This generally reflected the lowest level of antibody to these bacteria in healthy younger individuals, with no differences in antibody levels across age groups within the gingivitis population. Figure S1 presents the distribution of antibody across the age range in the periodontitis patients to three principal periodontal pathogens and shows no significant correlation of antibody with age to any of these oral pathogens associated with chronic adult periodontitis. Also noted in Figure 2b , antibody to some of the bacteria commonly considered as non-pathogenic commensal bacteria was also different with disease or ageing. Specifically, antibody to C. ochracea was significantly elevated in the periodontitis patients irrespective of age, while antibody to both A. naeslundii and Pr.
loescheii was elevated in the younger periodontitis patients compared to other age groups.
The antibody levels were then related to clinical parameters within the patient populations. As shown in the heat map in Figure The results in Table 2 indicate that, while levels of probing pocket depth (PPD) and clinical attachment loss (CAL) are minimal in and CAL with ageing was seen in the gingivitis patients. Importantly, to the consideration of age effects on disease, there was a loss of age correlation with all of the clinical parameters when the periodontitis patient category is sequestered from the overall population. Table 2 also depicts the relationship of the serum antibody levels to the bacteria in disease sites stratified on patient age. The results showed significant positive correlations in antibody level with P. gingivalis and T. denticola bacterial levels, but only in the youngest group. This specific antibody response and bacterial burden correlation were lost in the older patients.
As sex and smoking have been implicated as additional factors in the development and severity of periodontitis (Eke et al., 2016a; Nagarajan, Miller, Dawson, Al-Sabbagh, & Ebersole, 2016; Reynolds, 2014; Schulze & Busse, 2016; Timmerman & van der Weijden, 2006) , we evaluated the impact of smoking and sex within age categories on the antibody levels. As shown in Table 1 , there were more smokers in the periodontitis group and a consistent trend for the more severe disease group to have a higher proportion of smokers and lower proportion of females. Figure 5a summarizes sex effects on antibody responses in periodontitis patients across the age categories.
Frequently, females showed elevated antibody to the pathogens with significantly greater levels to A. actinomycetemcomitans and P. gingivalis and the average antibody response to the group of pathogens, but only in the oldest cohort. The results in Figure 5b show that antibody levels in smokers were elevated compared to non-smokers in multiple age categories, which paralleled the increased disease severity with smoking, but no trends that reflected an interaction of age and smoking in the antibody response levels were noted.
| D ISCUSS I ON
While substantial literature is available documenting levels of serum, gingival crevicular fluid and salivary antibody to oral bacteria as they relate to periodontitis, evidence is sparse regarding how these antibody responses are regulated with ageing (Ebersole et al., 2013 ).
However, even early studies of these responses that implied an increase in antibody levels with age really did not effectively distinguish the effect of ageing directly on the immune response system versus response profiles that reflected increased extent and severity of periodontitis, for example oral infection, with ageing (Mouton, Hammond, Slots, & Genco, 1981) . This study evaluated the systemic antibody responses to an array of oral bacteria including both putative pathogens and microorganisms considered part of the normal commensal ecology. Importantly, for the first time, we provided data that attempted to evaluate the impact of ageing on these adaptive immune responses isolated from the natural age-associated prevalence of periodontitis. The results demonstrated that ageing had a minimal effect on overall antibody levels to the range of oral bacteria that were tested, when patients were stratified based upon condition of the periodontium. While the gingival tissue exists within a mucosal environment in the oral cavity, and clearly saliva and the mucosal immune system bathe these tissues, the general paradigm in the literature is that the immune responses that impact the gingiva and subgingival sulcus are derived from the systemic immune system (Ebersole, Singer, Steffensen, Filloon, & Kornman, 1993; Lamster & Novak, 1992; Reinhardt, McDonald, Bolton, DuBois, & Kaldahl, 1989) . Thus, our focus was on examination of this arm of the immune response as related to ageing and periodontitis (Liljestrand et al., 2014) . Nevertheless, there is some literature suggesting variations in ageing effects on mucosal immune responses primarily related to Furthermore, we did observe that the total bacterial and pathogen burden in diseased sites were lower in the older population, which was unexpected based upon the epidemiologic data of more disease with ageing. These findings are consistent with the reported "inflammaging" with ageing, whereby a lower challenge to the system results in a chronically elevated and dysregulated inflammatory response (Franceschi & Campisi, 2014) . Moreover, this reported loss of control of inflammation in ageing that would contribute to the extent and severity of periodontitis was accompanied by a loss in the relationship between the levels of the microorganisms and the antibody levels in the older group. The combination of these alterations in the regulation of the host response to the altered oral microbiome in disease sites would be predicted to contribute to the underlying biologic basis for the epidemiologic findings of increased disease in ageing.
Overwhelming evidence is available identifying smoking as a crucial risk factor for periodontitis (Eke et al., 2016b; Genco & Borgnakke, 2013; Hujoel, 2003; Nagarajan et al., 2016; Reynolds, 2014) , as is found in most chronic diseases (Johannsen, Susin, & Gustafsson, 2014) . As ageing would be expected to reflect an increased magnitude of smoking, often expressed as "pack-years", we previously reported that cotinine levels and pack-years of smoking were specifically related to systemic inflammatory mediator and antibody levels in periodontitis (Ebersole, Steffen, Thomas, & AlSabbagh, 2014; Hayman et al., 2011) . However, as in most studies, we did not sequester the response profiles of smokers related to ageing, independent of the increased prevalence of periodontitis.
Smoking clearly impacts the prevalence and severity of periodontitis (Grossi et al., 1997; Hujoel, 2003; Tomar & Asma, 2000) , as well as antibody responses (Al-Ghamdi & Anil, 2007; Apatzidou, Riggio, TA B L E 2 Age-related correlations with clinical measures of periodontal disease and correlations of antibody levels to level of bacteria in subgingival plaque from diseased sites in the periodontitis patients Ebersole, 2017; Nagarajan et al., 2016; Quinn et al., 1996) , and this study did demonstrate that smokers in multiple age categories exhibited significantly elevated antibody to oral pathogens, compared to non-smokers that paralleled the increased disease severity with smoking. However, we saw no effect of smoking on the levels of antibody responses to periodontopathogens being affected by ageing. This relationship may reflect the long-term nature of the oral colonization/infection in these patients and, thus, a limited impact of the ageing process on this measure of adaptive immunity.
F I G U R E 5 (a) Serum antibody levels based on sex and stratified into age categories. (b) Serum antibody levels in smokers and non-smokers stratified into age groups. The bars denote group means, and the vertical brackets enclose 1 SD. The asterisk (*) denotes significantly different than other sex within an age category at least at p < .05
The history of periodontitis risk and expression related to sex has been limited in gaining a clear understanding of its effects on this disease. Many studies emphasized balancing groups based upon sex, with some assumptions on sex differences in periodontitis prevalence and severity. A recent review by Grover et al. (Grover, Jain, Kapoor, Malhotra, & Chahal, 2016) emphasized disparities in existing data, albeit males appeared more at risk than females although the underlying biologic and behavioural parameters that control this risk were unidentified. This tenet of male risk has been supported via multiple large epidemiologic studies (Eke et al., 2016b; Kongstad, Enevold, Christensen, Fiehn, & Holmstrup, 2017; Leite, Peres, Do, Demarco, & Peres, 2017) , which were similar in documenting an increased prevalence and severity of disease in males. We also found a higher frequency of males in the more severe disease groups, coupled with decreased antibody to periodontal pathogens in males.
More specifically, females showed elevated antibody to the pathogens with significantly greater levels to A. actinomycetemcomitans and P. gingivalis and the average antibody response to the group of pathogens, albeit this was most prominent in the oldest cohort.
There is negligible data available regarding antibody responses to oral bacteria affected by ageing and sex. However, these findings were consistent with our previous report in ageing non-human primates that demonstrated elevated systemic inflammatory mediators in ageing males and elevated specific antibody in ageing females who showed less periodontitis compared to the males . Furthermore, although not directly linked to ageing, we observed that elevated antibody to various oral bacteria in pregnant women with periodontitis was reflective of a lower risk of adverse pregnancy outcomes (Ebersole et al., 2009 (Lamster, Asadourian, Del Carmen, & Friedman, 2016) described the importance of differentiating normal ageing from disease with respect to the periodontium. Epidemiologic studies have also been conducted examining specific antibody responses to oral bacteria in periodontitis. These studies generally used large data sets derived from NHANES (Dye, Choudhary, Shea, & Papapanou, 2005; Dye et al., 2009) or the Atherosclerosis Risk in Communities (ARIC) Study (Beck et al., 2005) to examine antibody to various oral bacteria. Generally, antibody to certain of the bacteria was elevated in older subjects, males, smokers, minorities and type 2 diabetes and related to periodontitis clinical measures (Vlachojannis et al., 2010) .
However, while the patients are generally stratified based on age, these reports do not address the independent facet of ageing on the antibody responses, and the modelling did not discriminate age from an increased prevalence/severity of periodontitis. It is clear that molecular inflammation changes with ageing leading to the concept of "inflammaging", with substantial recent emphasis on ageing and innate immunity in the oral cavity (Ebersole, Graves et al., 2016) .
These reports described targeted mechanisms of innate immunity that are altered with ageing (Hajishengallis, 2010 (Hajishengallis, , 2014 , including various critical transcription factors and the resulting genes regulated by these factors (Chung et al., 2011) . Additionally, limited studies in animal models provide evidence for increased bone loss (Liang, Hosur, Domon, & Hajishengallis, 2010) , altered dendritic cell functions in response to bacterial infections (Wu et al., 2016) and substantial effects on the biology of B-cell functions in the oral cavity (Ebersole, Kirakodu et al., 2016 ) that would be considered to contribute to adaptive immune effects in the ageing oral cavity.
These data were accompanied by identification of an altered microbial challenge that likely also contributes to an adverse response profile (Feres, Teles, Teles, Figueiredo, & Faveri, 2016; Wu et al., 2016) . Only one recent report described antibody responses to oral bacteria in geriatric patients, albeit all had periodontitis of various levels of severity (Shet et al., 2015) . The results showed no differences in antibody responses to the "red complex" bacteria (Haffajee & Socransky, 2006) across periodontitis categories, while antibody to F. nucleatum increased with disease severity and levels to A. actinomycetemcomitans were most elevated in mild disease. This is becoming a more critical issue in the context of the expansion of the ageing population, the accurate estimate of the prevalence of the disease across the lifespan extending to risk of specific systemic diseases and finally clarifying the multidimensional nature of the aetiology, disease expression and treatment decisions that will impact the epidemiology, societal and economic impact of the disease on populations (Papapanou & Susin, 2017) .
In summary, the ageing process clearly contributes to the incidence and severity of periodontitis (Hajishengallis, 2014; Lamster, 2016; Lamster et al., 2016; Papapanou & Susin, 2017) and has been related to altered physiology that leads to a dysregulation of normal development, maturation, replenishment and response patterns of the immune system to the noxious challenge of the diseaseassociated oral microbiome (Ebersole, Graves et al., 2016) . However, our knowledge of ageing effects on adaptive immune response profiles and functional impact on oral microbes that have chronically colonized the oral cavity of individuals over many decades remains somewhat murky. This report is one of the first to attempt to isolate the ageing process from the disease process to assess the characteristics of antibody responses to pathogenic and commensal oral bacteria and identified a pattern that suggested that the magnitude of the response was not impacted by ageing, nor did age correlate with antibody responses to the oral pathogens in the periodontitis patients. However, the relationship of the antibody levels to the oral pathogens with the clinical disease parameters did vary with age, suggesting altered quality of the antibody may be a primary effect of ageing related to increased disease expression and severity in the aged population. 
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